Smith Devin Whittemore
SEC insider (Form 3/4/5 filer). CIK 0001747818. General Counsel at IO Biotech, Inc. (IOBT). 2 reported Form 4/5 transactions since Sep 2024; latest on Apr 2, 2025. Located in COPENHAGEN, G7.
Companies Smith Devin Whittemore has filed insider reports for
- IO Biotech, Inc. (IOBT): Officer, General Counsel
Smith Devin Whittemore
CIK: 0001747818
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IOBT
IO Biotech, Inc.
Officer